Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview

Nortriptyline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for nortriptyline hydrochloride and what is the scope of patent protection?

Nortriptyline hydrochloride
is the generic ingredient in four branded drugs marketed by Pharm Assoc, Mallinckrodt Inc, Mallinckrodt Llc, Taro Pharm, Teva, Mylan, Aurolife Pharma Llc, Mayne Pharma, Idt Australia Ltd, Taro, Lilly, and Ranbaxy, and is included in sixteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for nortriptyline hydrochloride. Thirty-four suppliers are listed for this compound.

Summary for Generic Name: nortriptyline hydrochloride

Drug Master File Entries: see list10
Suppliers / Packagers: see list34
Bulk Api Vendors: see list35
Clinical Trials: see list1,000
Patent Applications: see list1,562
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nortriptyline hydrochloride at DailyMed

Pharmacology for Ingredient: nortriptyline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurolife Pharma Llc
nortriptyline hydrochloride
CAPSULE;ORAL074835-004Jun 30, 1997DISCNNoNo► Subscribe► Subscribe
nortriptyline hydrochloride
CAPSULE;ORAL074234-004Jul 26, 1993ABRXNoNo► Subscribe► Subscribe
nortriptyline hydrochloride
CAPSULE;ORAL074132-003Mar 27, 1995ABRXNoNo► Subscribe► Subscribe
nortriptyline hydrochloride
SOLUTION;ORAL014685-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Mallinckrodt Llc
nortriptyline hydrochloride
CAPSULE;ORAL018013-004Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus